The global Biomaterial Market was valued at $62,068.0 million in 2015 and it is expected to grow at a CAGR of 16.1% during 2016-2022.  The polymer biomaterial segment in the global biomaterial market is expected to witness the fastest growth, a CAGR of 19.8% during the forecast period. 

Related Articles

The global biomaterial market is growing at a significant rate, due to increasing healthcare expenditure, growing geriatric population and increasing incidence of cardiovascular diseases.  The technological advancement in biomaterials, growing demand of implantable devices, and increasing incidence of hip and knee replacements are also driving the growth of the global biomaterial market.  However, factors such as strict regulatory requirements for approval of biomaterials and limitations of biomaterials are inhibiting growth of the market globally. 

Biomaterial is a nonviable material used in medical devices or during interaction with biological systems.  It is an essential material used for medical applications to substitute a part or a function of body in reliable, safe, and physiologically acceptable method.  It poses properties such as biocompatibility, high corrosion resistance, adequate strength, and biofunctionality.  Some of the commonly used biomaterials include cellulose, silicone rubber, collagen, titanium, stainless steel, polyurethanes, poly (methyl methacrylate) and hydrogels.  The emergence of innovative biomaterial products and advances in technology has improved biomaterials applications and performance. 

Geographically, North America dominated the global market of biomaterial in 2015.  Asia-Pacific is expected to witness the fastest growth, a CAGR of 18.3% during the forecast period.  This is due to increasing geriatric population, increasing healthcare expenditure, increasing research & development, and growing incidence of cardiovascular diseases in the region.